Suven Life Sciences Ltd. (SUVEN): Suven Life Sciences Share Price Hits Fresh 52-Week High
- August 21, 2026
- Posted by: Harsh Piplani
- Category: News
Suven Life Sciences Share Price rose to Rs 383.8, up 2.5% today, after hitting a fresh 52-week high of Rs 388.4. The company’s market capitalisation stood at Rs 9,389.56 crore.
Suven Life Sciences Share Price was at Rs 383.8 on 21 August 2026 at 9:52 AM IST, up Rs 9.35 or 2.5% from the previous close of Rs 374.45, after the stock touched a fresh 52-week high of Rs 388.4. At this level, the company carried a market capitalisation of Rs 9,389.56 crore, making it a notable market mover within the Healthcare space.
This Suven Life Sciences Share Price Today move stands out because the stock not only traded above its previous close but also printed a new one-year high during the session. The verified data confirms the price event and elevated investor attention, with turnover at Rs 3.47 crore and volume at 90,329 shares. The supplied data confirms what happened in the market, though it does not establish a company-specific catalyst behind the move.
For investors following Suven Life Sciences Stock News, the key questions now are straightforward: how strong was today’s price action, what do the available fundamentals say about the business at this market value, and how does the stock compare with its Healthcare sector benchmark and listed peers. This Univest analysis focuses on those verified data points without stretching beyond them.
Suven Life Sciences Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 383.8 |
| Previous Close | Rs 374.45 |
| Today's Change | +Rs 9.35 (+2.5%) |
| Day Open | Rs 375.45 |
| Fresh 52-Week High | Rs 388.4 |
| Day Low | Rs 366.15 |
| Current Volume | 90,329 |
| Turnover | Rs 3.47 crore |
| Market Capitalisation | Rs 9,389.56 crore |
Suven Life Sciences Ltd. (SUVEN) traded at Rs 383.8. versus the previous close of Rs 374.45, a rise of 2.5%. The stock opened at Rs 375.45, reached Rs 388.4, touched Rs 366.15. Reported volume was 90,329.
Suven Life Sciences Share Price Today moved higher from the previous close, opened above that level, and went on to register a fresh 52-week peak. The session shows positive intraday momentum, active participation and a clear one-year high, which makes the stock relevant in current stock market today screens.
The stock opened at Rs 375.45 against a previous close of Rs 374.45, indicating a firm start to the day. It then rose to an intraday high of Rs 388.4, which now marks the fresh 52-week high, before trading at Rs 383.8 at the time of the article. The day’s low was Rs 366.15, so the trading range remained wide even as the stock finished well above the previous close.
In absolute terms, the day change was Rs 9.35, while the percentage gain stood at 2.5%. That combination matters because it shows the stock was not merely testing its prior band but had extended into a new yearly high zone. The move also came with turnover of Rs 3.47 crore and traded volume of 90,329 shares, confirming that the Suven Life Sciences Share Price Update is backed by measurable market activity rather than an isolated print.
From a price action perspective, a fresh 52-week high often puts a stock on traders’ and investors’ watchlists because it signals that the market is willing to transact at the highest level seen over the last year. In Suven Life Sciences Share News terms, that is the central verified development today. The next step is to examine whether the available fundamental metrics add support or caution to the move.
Suven Life Sciences Ltd. (SUVEN) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 9,389.56 crore |
| P/E Ratio | 50.55x |
| P/B Ratio | 1.94x |
| ROE | -0.78% |
| ROCE | 8.31% |
Suven Life Sciences Ltd. was valued at a P/E ratio of 50.55x, a P/B ratio of 1.94x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.
Profitability and capital efficiency were represented by ROE of -0.78% and ROCE of 8.31%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Benchmark Scope | same sector |
| Company P/E Ratio | 50.55x |
| Benchmark Median P/E | 21.42x |
| Benchmark Average P/E | 48.98x |
| Benchmark P/E Range | 0x to 1,614.49x |
| Company P/B Ratio | 1.94x |
| Benchmark Median P/B | 1.94x |
| Company ROE | -0.78% |
| Benchmark Median ROE | 11.09% |
| Company ROCE | 8.31% |
| Benchmark Median ROCE | 13.29% |
| Company Market Capitalisation | Rs 9,389.56 crore |
| Benchmark Median Market Cap | Rs 132.66 crore |
Suven Life Sciences Ltd. (SUVEN) is classified under sector: Healthcare.
Suven Life Sciences Ltd. (SUVEN) has a P/E ratio of 50.55x, which is above the benchmark median of 21.42x, a difference of +135.99%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Suven Life Sciences Ltd. (SUVEN) has a ROE of -0.78%, which is below the benchmark median of 11.09%, a difference of -107.03%. Suven Life Sciences Ltd. (SUVEN) has a ROCE of 8.31%, which is below the benchmark median of 13.29%, a difference of -37.47%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Ind-Swift Laboratories Ltd. | INDSWFTLAB | 2,803.21 | 50.55 | 1.94 | -0.78 | 8.31 |
| Dishman Carbogen Amcis Ltd. | DCAL | 2,700.59 | 166.73 | 0.41 | -2.89 | -0.26 |
| Beta Drugs Ltd. | BETA | 2,668.21 | 61.53 | 9.73 | 18.65 | 22.17 |
| Dr Agarwals Eye Hospital Ltd. | DRAGARWQ | 2,566.23 | 33.67 | 6.94 | 36.29 | 42.4 |
| Sai Parenteral's Ltd. | SAIPARENT | 2,386.78 | 142.94 | 3.09 | 13.9 | 12.97 |
Suven Life Sciences Ltd. (SUVEN) has a P/E ratio of 50.55x compared with the displayed peer median of 61.53x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of -0.78% compares with a peer median of 13.9% across the companies shown in the table. ROCE stood at 8.31% versus the displayed peer median of 12.97%, providing a capital-efficiency comparison. Suven Life Sciences Ltd. (SUVEN) has a market capitalisation of Rs 9,389.56 crore. Among the 5 peers shown, 0 have a larger market capitalisation.
Why Investors Are Watching Suven Life Sciences
The stock is attracting attention because the verified data combines a fresh yearly high with a sizeable market capitalisation and a valuation profile that sits above sector-median earnings multiples. Here are the main factors behind current investor focus.
- The stock touched a fresh 52-week high of Rs 388.4 and was trading at Rs 383.8, up 2.5% from the previous close of Rs 374.45.
- Opening at Rs 375.45 and moving within a day range of Rs 366.15 to Rs 388.4 shows active intraday price action.
- Turnover of Rs 3.47 crore and volume of 90,329 shares confirm that the move came with measurable participation.
- The company’s market capitalisation of Rs 9,389.56 crore is far above the supplied Healthcare sector median and average.
- The P/E ratio of 50.55 is above the sector median of 21.42, while the P/B ratio of 1.94 matches the sector median exactly.
- ROE of -0.78 and ROCE of 8.31 trail the sector medians of 11.09 and 13.29, making the fundamental picture mixed rather than one-sided.
About Suven Life Sciences
Suven Life Sciences Ltd. is classified in the Healthcare sector in the supplied data. The peer universe attached to this stock event largely includes Pharmaceuticals & Drugs companies, along with selected Healthcare service names, which gives investors a broad listed-sector frame for comparison.
Based on the verified dataset used for this article, the company is being assessed primarily through market data and broad financial ratios rather than a detailed operating profile. That means the most relevant current context is how Suven Life Sciences is being priced by the market: a Rs 9,389.56 crore company trading at 50.55 times earnings and 1.94 times book value, with ROE of -0.78 and ROCE of 8.31, and now drawing attention after a fresh one-year high.
For readers looking at Suven Life Sciences Stock News and Suven Life Sciences Share Price Live trends, the present story is more about market positioning than business-description depth. On Univest, the stock currently stands out because it has entered the 52 Week High Stocks screen while carrying a much larger market cap than the supplied sector benchmark basket.
Track Suven Life Sciences Share Price on Univest
Use Suven Life Sciences Ltd. (SUVEN) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
Investors tracking Suven Life Sciences Share Price can use Univest to follow live share price movements, 52-week levels, valuation ratios, sector comparisons and broader stock analysis in one place. For users monitoring Suven Life Sciences News Today, the platform helps connect price action with market cap, P/E, P/B, ROE and ROCE rather than viewing a fresh high in isolation.
Univest also helps readers place a move like this in context with peer comparison, market insights and ongoing share price news. When a stock enters the one-year high zone, investors typically monitor whether price action remains active, whether valuation stays aligned with fundamentals and how the company compares with sector benchmarks over time. That is the most practical way to read the current Suven Life Sciences Share Price Today move without turning it into a recommendation.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
What is the latest Suven Life Sciences Share Price Today?
Ans. Suven Life Sciences Share Price Today was Rs 383.8 at the time of this article. The stock was up Rs 9.35, or 2.5%, from the previous close of Rs 374.45 after touching a fresh 52-week high.
Why is Suven Life Sciences Share Price in focus today?
Ans. The stock is in focus because it touched a fresh 52-week high of Rs 388.4 during the session. It also traded with turnover of Rs 3.47 crore and volume of 90,329 shares, keeping investor attention elevated.
What was the fresh 52-week high for Suven Life Sciences?
Ans. Suven Life Sciences hit a fresh 52-week high of Rs 388.4 on 21 August 2026. At the time of writing, the stock was trading at Rs 383.8, slightly below the intraday peak but still above the previous close.
How did Suven Life Sciences trade during the session?
Ans. The stock opened at Rs 375.45, moved between a day low of Rs 366.15 and a day high of Rs 388.4, and was trading at Rs 383.8 when this article was published on Univest.
What is the market capitalisation of Suven Life Sciences?
Ans. Suven Life Sciences had a market capitalisation of Rs 9,389.56 crore based on the supplied data. That is far above the Healthcare sector median market cap of Rs 132.66 crore and average of Rs 467.25 crore.
Is Suven Life Sciences expensive compared with the Healthcare sector?
Ans. On the supplied numbers, the P/E ratio of 50.55 is above the Healthcare sector median of 21.42 and slightly above the average of 48.98. The P/B ratio of 1.94, however, matches the sector median exactly.
How do Suven Life Sciences return ratios compare with the sector?
Ans. Suven Life Sciences reported ROE of -0.78 and ROCE of 8.31. Both are below the Healthcare sector median levels of 11.09 for ROE and 13.29 for ROCE in the supplied benchmark snapshot.
How does Suven Life Sciences compare with selected peers?
Ans. The supplied peers show mixed positioning. Suven Life Sciences has a higher market cap than the named peers, while several peers such as Beta Drugs and Dr Agarwals Eye Hospital show stronger ROE and ROCE figures.
What does the P/B ratio indicate for Suven Life Sciences?
Ans. The stock’s P/B ratio is 1.94, which is exactly equal to the Healthcare sector median of 1.94 and below the sector average of 2.57. That suggests book-value valuation is broadly in line with the benchmark.
What should investors monitor after this Suven Life Sciences 52-week high?
Ans. Investors may track whether the stock holds above recent breakout levels, how trading activity evolves after the fresh high, and whether valuation metrics such as P/E 50.55 remain supported against sector and peer comparisons.
